Interestingly, ex vivo, these CCR5+ TA-Tregs are more potent suppressors than their CCR5neg counterparts [107], suggesting that CCR5 expression not only favors Treg recruitment to the tumor but, also, defines a subset with more potent suppressive functions. Here, CCR5 is linked to neoplasm.